Overview

Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)

Status:
Withdrawn

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate whether the use of ACTH in addition to Avonex is effective in the treatment of relapsing remitting multiple sclerosis.

Phase:

Phase 2

Details

Lead Sponsor:

University at Buffalo

Treatments:

Adrenocorticotropic Hormone
beta-Endorphin
Melanocyte-Stimulating Hormones